JP2023546452A5 - - Google Patents
Info
- Publication number
- JP2023546452A5 JP2023546452A5 JP2023524274A JP2023524274A JP2023546452A5 JP 2023546452 A5 JP2023546452 A5 JP 2023546452A5 JP 2023524274 A JP2023524274 A JP 2023524274A JP 2023524274 A JP2023524274 A JP 2023524274A JP 2023546452 A5 JP2023546452 A5 JP 2023546452A5
- Authority
- JP
- Japan
- Prior art keywords
- solvate
- pharmaceutically acceptable
- acceptable salt
- compound according
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063094808P | 2020-10-21 | 2020-10-21 | |
| US63/094,808 | 2020-10-21 | ||
| PCT/IB2021/000708 WO2022084739A1 (en) | 2020-10-21 | 2021-10-20 | Compounds and methods for the treatment of ocular disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023546452A JP2023546452A (ja) | 2023-11-02 |
| JP2023546452A5 true JP2023546452A5 (https=) | 2024-10-29 |
Family
ID=81290138
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023524274A Pending JP2023546452A (ja) | 2020-10-21 | 2021-10-20 | 眼障害を処置するための化合物および方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230399317A1 (https=) |
| EP (1) | EP4232034A4 (https=) |
| JP (1) | JP2023546452A (https=) |
| KR (1) | KR20230110516A (https=) |
| CN (1) | CN116635032A (https=) |
| AU (1) | AU2021365530A1 (https=) |
| CA (1) | CA3196146A1 (https=) |
| IL (1) | IL302174A (https=) |
| MX (1) | MX2023004538A (https=) |
| WO (1) | WO2022084739A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024100454A2 (en) * | 2022-11-11 | 2024-05-16 | Azura Ophthalmics Ltd. | Composition and methods for improving signs and symptoms of ocular disorders |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2830024T3 (es) * | 2007-10-19 | 2021-06-02 | Novartis Ag | Composiciones y métodos para el tratamiento del edema macular |
| US20090257957A1 (en) * | 2008-04-15 | 2009-10-15 | John Burnier | Aerosolized LFA-1 antagonists for use in localized treatment of immune related disorders |
| BR112015014367B1 (pt) * | 2012-12-19 | 2022-11-22 | Novartis Ag | Composição inibidora de lfa-1, método para estabilizar a dita composição e uso da mesma para tratar uma doença ocular |
| US9463201B2 (en) * | 2014-10-19 | 2016-10-11 | M.G. Therapeutics Ltd | Compositions and methods for the treatment of meibomian gland dysfunction |
| US10688122B2 (en) * | 2015-09-28 | 2020-06-23 | Azura Ophthalmics Ltd. | Thiol and disulfide-containing agents for increasing meibomian gland lipid secretion |
| JP2019513775A (ja) * | 2016-04-19 | 2019-05-30 | アズーラ オフサルミックス エルティーディー． | 角化症の処置のための組成物 |
| EP3600272A4 (en) * | 2017-03-29 | 2021-01-13 | Azura Ophthalmics Ltd. | MEANS OF INCREASING LIPID SECRETION OF THE MEIBOMAN GLAND |
| WO2018212846A1 (en) * | 2017-05-19 | 2018-11-22 | Ocugen, Inc. | Ophthalmic compositions and methods of use |
| US20180333357A1 (en) * | 2017-05-19 | 2018-11-22 | Ocugen, Inc. | Nanoemulsions with anti-inflammatory activity |
| WO2019053607A1 (en) * | 2017-09-18 | 2019-03-21 | Glenmark Pharmaceuticals Limited | PROCESS FOR PREPARING LIFITEGRAST |
| US11001574B2 (en) * | 2017-11-17 | 2021-05-11 | Medichem S.A. | Process to obtain a tetrahydroisoquinoline derivative |
| WO2020212755A1 (en) * | 2019-04-18 | 2020-10-22 | Azura Ophthalmics Ltd. | Compounds and methods for the treatment of ocular disorders |
| JP7700045B2 (ja) * | 2019-04-18 | 2025-06-30 | アズーラ オフサルミックス エルティーディー． | 眼障害を処置するための化合物および方法 |
-
2021
- 2021-10-20 EP EP21882227.8A patent/EP4232034A4/en active Pending
- 2021-10-20 KR KR1020237016473A patent/KR20230110516A/ko active Pending
- 2021-10-20 IL IL302174A patent/IL302174A/en unknown
- 2021-10-20 WO PCT/IB2021/000708 patent/WO2022084739A1/en not_active Ceased
- 2021-10-20 JP JP2023524274A patent/JP2023546452A/ja active Pending
- 2021-10-20 AU AU2021365530A patent/AU2021365530A1/en not_active Abandoned
- 2021-10-20 MX MX2023004538A patent/MX2023004538A/es unknown
- 2021-10-20 CA CA3196146A patent/CA3196146A1/en active Pending
- 2021-10-20 US US18/033,055 patent/US20230399317A1/en active Pending
- 2021-10-20 CN CN202180086872.2A patent/CN116635032A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023546453A5 (https=) | ||
| ES2393424T3 (es) | Agente farmacéutico que contiene un agonista de PPAR-delta | |
| JP2022529315A5 (https=) | ||
| DE69814012D1 (de) | Hypoglykàmische imidazoline derivate | |
| EP3069612A2 (en) | Dithiol compounds, derivatives, and uses therefor | |
| KR920000788A (ko) | 폴리펩티드 화합물 및 그것의 제조방법 | |
| JP2023546452A5 (https=) | ||
| SG189161A1 (en) | Sodium salt of 6-fluoro-3-hydroxy-2-pyrazine carboxamide | |
| JP2023546915A5 (https=) | ||
| CN107921031A (zh) | 给予谷氨酰胺酶抑制剂的方法 | |
| KR20100131976A (ko) | 고 안압증의 치료를 위한 디플루오로바이페닐아미드 유도체 | |
| US20210101923A1 (en) | Nucleic acid prodrugs | |
| JP7165358B2 (ja) | 角膜保護用の組成物 | |
| RU2011140701A (ru) | Замещенные 3-амино-2-меркаптохинолины в качестве kcnq2/3 модуляторов | |
| EP1515729B1 (en) | Quaternised ammonium cyclodextrin compounds | |
| EP0842165B1 (en) | Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents | |
| CA2491612A1 (en) | 4-'7-halo-2-quino(xa-)linyloxy!phenoxy-propionic acid derivatives as antineoplastic agents | |
| HU210675B (en) | Process for producing 3,3'-dithio-bis(propionic-acid) derivatives and esters thereof and pharmaceutical compositions containing the same | |
| RU2008112181A (ru) | Применение конденсированных производных имидазола для лечения заболеваний, опосредованных рецептором ccr3 | |
| RU2014132830A (ru) | Конъюгаты антагонистов интегрина для нацеленной доставки к клеткам, экспрессирующим vla-4 | |
| JP2017534658A5 (https=) | ||
| KR880001593A (ko) | 4-(아로일아미노)피페리딘부탄아미드 유도체 | |
| CA2642453A1 (en) | Methoxypolyethylene glycol thioester chelate and uses thereof | |
| CA2458266A1 (en) | Substituted urea retinoid agonists ii | |
| JP2010513262A5 (https=) |